Immune reactivity against a variety of mammalian milks and plant-based milk substitutes
Posted by Leanne Kodsman on
Single Donor Human Serum from Innovative Research was recently used in the following study:
Journal of Dairy Research, August 2018
Immune reactivity against a variety of mammalian milks and plant-based milk substitutes
Aristo Vojdani, Chris Turnpaugh, and Elroy VojdaniJournal of Dairy Research, August 2018
"... Five hundred sera from a cross-spectrum population aged 18-65 were obtained from Innovative Research (Novi, MI, USA). The healthy subjects were tested according to FDA guidelines for the detection of hepatitis B surface antigen, antibodies to HIV, HIV-1 RNA, Hepatitis-C RNA, and syphilis. All samples yielded non-reactive or negative results for each test performed..."
Related products available from Innovative Research also include:
The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!
Related Posts
Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
In the ever-evolving landscape of molecular biology, precision tools are essential for ...
Read the ArticleRevolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
Read the ArticlePioneering Advances in Complement-Mediated Disorders: An In-depth Look at SAR443809
In the dynamic landscape of medical research, SAR443809 emerges as a promising candidat...
Read the Article